Andrew Hykes - Jan 18, 2022 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Jan 18, 2022
Transactions value $
-$383,244
Form type
4
Date filed
1/20/2022, 07:50 PM
Previous filing
Jan 4, 2022
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale -$92.4K -1.22K -0.77% $75.46 157K Jan 18, 2022 Direct F1, F2
transaction NARI Common Stock Sale -$151K -1.98K -1.26% $76.58 155K Jan 18, 2022 Direct F1, F3
transaction NARI Common Stock Sale -$108K -1.4K -0.9% $77.31 153K Jan 18, 2022 Direct F1, F4
transaction NARI Common Stock Sale -$31.3K -400 -0.26% $78.29 153K Jan 18, 2022 Direct F1, F5, F6
holding NARI Common Stock 1.55K Jan 18, 2022 By Child 2
holding NARI Common Stock 1.55K Jan 18, 2022 By Child 1
holding NARI Common Stock 1.55K Jan 18, 2022 By Child 3
holding NARI Common Stock 1K Jan 18, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $74.98 to $75.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $76.05 to $77.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $77.05 to $77.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $78.15 to $78.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This amount reflects an updated holding to correct a typographical error in the total on a prior report. It also includes 695 shares acquired under the Employee Stock Ownership Plan in 2021.